Purpose: Independent ethical review committees safeguard participants in human research. The purpose of this study was to describe the current ethical guidelines for human research requirements in the Instructions to Authors of the English language medical journals previously studied in 1995. Methods: The instructions to authors of English language medicine journals from the Abridged Index Medicus were searched for any policies regarding guidance on the ethical treatment of human subjects in research.
History provides numerous examples of harmful human research. 1 In response, distinguished organizations (such as the World Association of Medical Editors (WAME) and the World Health Organization (WHO)) have issued ethical guidance and governments have created independent ethics committees to safeguard study participants. 1 While concerns remain regarding the performance of individual ethical review committees in fulfilling their mission, 2, 3 these committees embody an undeniable advance for ensuring patient safety. In addition, articles reporting ethics committee approval of protocols are generally of higher methodological quality than articles that do not. 4 In 1997, Amdur and Biddle reported that only 47% of medical journal Instructions to Authors called for disclosing independent ethics review committee approval in manuscripts reporting human research and that 24% did not provide any information on human research ethics. 5 Because ethical issues in human research are increasingly debated in both scientific forums and popular media, 2-4,6,7 we repeated Amdur and Biddle's study to determine what changes have occurred regarding ethics committee journal disclosure guidelines over the past decade. (Table 1) .
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Instructions to authors of 84/101 (83%) medical journals required independent ethics review committee approval for studies using human subjects: 8/101 (8%) made reference to other guidelines that call for approval by an independent ethics review committee [5/101 (5%) ICJME Uniform Requirements, 3/101 (3%) Declaration of Helsinki], 1/101 (1%) stated that informed consent should be obtained, and 8/101 (8%) journals did not mention human research ethics guidelines (Table 2) .
Of the 84 medical journals with Instructions to Authors calling for ethics committee approval for human studies, 71 (85%) required that a statement disclosing independent ethics committee approval appear in the manuscript, 5 (6%) required separate documents certifying independent ethics committee approval, 8 (10%) assumed compliance and zero required a copy of the independent ethics committee approval letter (Table 3) .
Discussion
Ten years ago, 24% of the medical journal Instructions to Authors examined provided no ethical guidelines for research involving humans. This percentage has decreased to 8%. These findings reflect the growing pressure clinical investigators face in addressing ethics committee concerns regarding research design, conflicts of interest, and subject privacy. 6, 10, 11 The number of journals requiring documentation of ethics committee approval, however, has not changed [7/48 vs 5/84 journals (P=0.10)]. A major development since Amdur and Biddle's study has been the mandatory prospective registration of clinical trials by numerous journals. [12] [13] [14] While the trial registration database "ClinicalTrials.gov" requires ethical committee approval before patient enrollment and contains approved protocol information, 15 documentation of ethics committee approval is not generally required by registries. For example, the International Committee of Medical Journal Editors (ICJME) asserts that "it is assumed that all registered trials will be approved by an ethics board before commencing," but does not require documentation, 16 and the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) recommends, but does not require, ethics approval before patient enrollment. 17 To further ensure the integrity of scientific journal publications, 18 medical journals should require submission and online posting of approved human research protocols and copies of independent ethics committee certification letters in an open repository. Online posting of approval letters and protocols are logical extensions of policies requiring ethics committee review; these additional measures will promote ethical conduct and foster the archiving of the experimental methods. 19, 20 International consensus on posting may be promoted by international consortia (e.g., ICJME) and organizations (e.g. the World Association of Medical Editors). Similar precedent for online access to critical information has been established with database deposition of protein crystallography, gene sequence and microarray data for publication in protein structure, genetic and gene expression publications. 21 Concern regarding patient privacy and loss of researchers' competitive advantage may arise with the publishing of detailed experimental protocols. While the HIPAA Privacy Rule has been reported to hinder biomedical research on several fronts in the US, HI-PAA was designed to protect the privacy of individually identifiable health information, striking a balance between patient privacy and the disclosure of medical data that have been properly deidentified. 22 Clearly, protocols can be described without patient data being revealed. Still, investigators and pharmaceutical companies may consider protocols trade secrets, so the benefits of increased transparency will need to be weighed against any disincentive mandatory protocol registration will have on medical research.
The lengthening list of abuses of human subjects accompanying the shift of clinical research from academic centres to the less regulated private sector 7 fact of human behaviour is that there will always be those among us who cheat. For researchers who have obtained ethics committee approval, providing a copy of the approval letter is minimal additional work.
Creating such a document is much more problematic for researchers who have not received approval. Likewise subjects may expose experimenters altering posted protocols and thereby effectively supplement the work of data safety monitoring boards to protect human research. The minimal extra work involved in requiring online posting of clinical trial documents is a small price for the benefits that open review and transparency will provide.
